8-KRegulation FD

Elevance Health, Inc. 8-K Report, Regulation FD Disclosure (Mar 9, 2020)

Filed March 9, 2020For Securities:ELV

Summary

Elevance Health, Inc. (formerly Anthem, Inc.) filed an 8-K on March 9, 2020, to disclose information shared with investors during meetings scheduled between March 10 and March 31, 2020. The primary focus of this disclosure is the reaffirmation of the company's financial guidance for the full year 2020. Management expects net income to exceed $21.44 per share, which includes an estimated $0.86 per share in net unfavorable items. Consequently, adjusted net income is projected to be greater than $22.30 per share. This guidance is based on the financial performance and trends observed up to the filing date and does not incorporate any new adjustment items beyond those previously reported for fiscal year 2019. Investors should note that this information is furnished and not deemed filed, and forward-looking statements within the report are subject to various risks and uncertainties that could materially impact actual results.

Key Highlights

  • 1Elevance Health (ELV) reaffirmed its full-year 2020 net income guidance.
  • 2Projected net income for 2020 is expected to be greater than $21.44 per share.
  • 3Guidance includes approximately $0.86 per share of net unfavorable items.
  • 4Adjusted net income is projected to be greater than $22.30 per share.
  • 5The guidance does not include adjustment items beyond those reported in the FY 2019 earnings release.
  • 6Information was disclosed during investor meetings from March 10 to March 31, 2020.
  • 7The filing includes a cautionary statement regarding forward-looking statements and associated risks.

Frequently Asked Questions

The primary purpose of this 8-K filing is to disclose financial guidance for the full year 2020 that Elevance Health (ELV) officers intended to discuss with investors during scheduled meetings.

Elevance Health projects its net income for the full year 2020 to be greater than $21.44 per share. After accounting for approximately $0.86 per share in net unfavorable items, the adjusted net income is expected to be greater than $22.30 per share.

No, the guidance provided for 2020 does not include any adjustment items beyond those that were already reported in the company's full-year 2019 earnings release. This implies the guidance is based on existing known factors and trends.

Information 'furnished' under Regulation FD, such as this disclosure, is generally not considered 'filed' with the SEC for purposes of Section 18 of the Securities Exchange Act of 1934. This means it may not carry the same legal implications as 'filed' information, although it still provides material updates to investors. It also will not be automatically incorporated by reference into other SEC filings unless specifically stated.